Firms
Theme

CSWC

Capital Southwest Corp · NASDAQ

News

3 latest

Zacks Investment Research

Capital Southwest (CSWC) Upgraded to Buy: Here's Why

Capital Southwest (CSWC) has been upgraded to a Zacks Rank #2 (Buy) rating due to upward trends in earnings estimates. The company's consensus estimate for fiscal year 2027 remains at $2.27 per share, with analysts raising estimates by 1.5% over the past three months. The upgrade positions CSWC in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation.

Zacks Investment Research

These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

The article highlights two finance stocks with positive Earnings Surprise Prediction (ESP) figures that could beat upcoming earnings estimates. Capital Southwest (CSWC) has a +2.96% ESP with a #3 (Hold) rating and reports earnings on November 2, 2026.

Zacks Investment Research

Will Capital Southwest (CSWC) Beat Estimates Again in Its Next Earnings Report?

Capital Southwest (CSWC), a business development company, has a strong track record of beating earnings estimates with an average surprise of 4.60% over the past two quarters. The company currently has a positive Earnings ESP of +2.96% combined with a Zacks Rank #3 (Hold), suggesting a high probability of another earnings beat in its next report expected on November 2, 2026.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CSWC · 0 threads

Sign in to post on $CSWC

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev